Skip to main content

toppbild-press-1551x278.jpg

Press

Interview with CEO Anna Ljung

Link to video »
  • All pressreleases
  • Regulatory
2022-11-08 | Press release
Moberg Pharma´s Interim report January - September 2022
2022-11-03 | Press release
Moberg Pharma’s nomination committee appointed
2022-08-09 | Press release
Moberg Pharma´s interim report January - June 2022

Read more »

2022-11-08 | Press release
Moberg Pharma´s Interim report January - September 2022
2022-08-09 | Press release
Moberg Pharma´s interim report January - June 2022
2022-08-04 | Press release
Moberg Pharma and Padagis sign agreement for MOB-015 in Israel

Read more press releases »

Latest report

2022-11-08 Moberg Pharma´s Interim report January - September 2022

Contact for press och media:

Anna Ljung, CEO
Phone: +46 8 522 307 08
Email: anna.ljung@mobergpharma.se
 

Subscribe

Get our latest press releases and reports

 

Calendar/presentations

Next calendar event: 2023-02-07 Year-end report 2022

IMAGE BANK  »